Regular Article
Self-Assembly of β-Amyloid 42 Is Retarded by Small Molecular Ligands at the Stage of Structural Intermediates

https://doi.org/10.1006/jsbi.2000.4241Get rights and content

Abstract

Assemblyof the amyloid-β peptide (Aβ) into fibrils and its deposition in distinct brain areas is considered responsible for the pathogenesis of Alzheimer's disease (AD). Thus, inhibition of fibril assembly is a potential strategy for therapeutic intervention. Electron cryomicroscopy was used to monitor the initial, native assembly structure of Aβ42. In addition to the known fibrillar intermediates, a nonfibrillar, polymeric sheet-like structure was identified. A temporary sequence of supramolecular structures was revealed with (i) polymeric Aβ42 sheets during the onset of assembly, inversely related to the appearance of (ii) fibril intermediates, which again are time-dependently replaced by (iii) mature fibrils. A cell-based primary screening assay was used to identify compounds that decrease Aβ42-induced toxicity. Hit compounds were further assayed for binding to Aβ42, radical scavenger activity, and their influence on the assembly structure of Aβ42. One compound, Ro 90-7501, was found to efficiently retard mature fibril formation, while extended polymeric Aβ42 sheets and fibrillar intermediates are accumulated. Ro 90-7501 may serve as a prototypic inhibitor for Aβ42 fibril formation and as a tool for studying the molecular mechanism of fibril assembly.

References (69)

  • S.A. Gravina et al.

    Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)

    J. Biol. Chem.

    (1995)
  • J.D. Harper et al.

    Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein

    Chem. Biol.

    (1997)
  • J.D. Harper et al.

    Observation of metastable Abeta amyloid protofibrils by atomic force microscopy

    Chem. Biol.

    (1997)
  • D. Howlett et al.

    Hemin and related porphyrins inhibit beta-amyloid aggregation

    FEBS Lett.

    (1997)
  • D.R. Howlett et al.

    Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide

    Neurodegeneration

    (1995)
  • H. Inouye et al.

    Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: Analysis by x-ray diffraction

    Biophys. J.

    (1993)
  • J.T. Jarrett et al.

    Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?

    Cell

    (1993)
  • R. Karlsson et al.

    J. Immunol. Methods

    (1991)
  • E. Kellenberger et al.

    The wrapping phenomenon in air-dried and negatively stained preparations

    Ultramicroscopy

    (1982)
  • D.A. Kirschner et al.

    In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice

    J. Struct. Biol.

    (1998)
  • P. Kuner et al.

    Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands

    J. Biol. Chem.

    (2000)
  • P.T. Lansbury

    Structural neurology: Are seeds at the root of neuronal degeneration?

    Neuron

    (1997)
  • S.B. Malinchik et al.

    Structural analysis of Alzheimer's beta(1-40) amyloid: Protofilament assembly of tubular fibrils

    Biophys. J.

    (1998)
  • D. Moechars et al.

    Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

    J. Biol. Chem.

    (1999)
  • C.J. Pike et al.

    In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

    Brain Res.

    (1991)
  • A.E. Roher et al.

    Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease

    J. Biol. Chem.

    (1996)
  • B. Seilheimer et al.

    The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology

    J. Struct. Biol.

    (1997)
  • L.C. Serpell et al.

    Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs

    J. Mol. Biol.

    (1995)
  • D.M. Walsh et al.

    Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate

    J. Biol. Chem.

    (1997)
  • D.M. Walsh et al.

    Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

    J. Biol. Chem.

    (1999)
  • S.J. Wood et al.

    Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta

    J. Mol. Biol.

    (1996)
  • M.O. Chaney et al.

    Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease

    Protein Eng.

    (1998)
  • M.C. Chartier-Harlin et al.

    Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

    Nature

    (1991)
  • H. Döbeli et al.

    A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide

    Biotechnology

    (1995)
  • Cited by (55)

    • Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism

      2017, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Ro 90-7501 might exert its inhibitory effect on PP5 by binding to the TPR domain and tightening the autoinhibited conformation of PP5. It has been reported that Ro 90-7501 efficiently retarded mature fibril formation of amyloid-β which is considered responsible for Alzheimer's disease [26]. Another research showed that Ro 90-7501 enhanced TLR/RLR agonist induced antiviral response, possibly via selective activation of p38 MAPK pathway [27].

    • Inhibition of amyloid fibril formation and cytotoxicity by a chemical analog of Curcumin as a stable inhibitor

      2015, International Journal of Biological Macromolecules
      Citation Excerpt :

      Classical suggested approaches to treat amyloidogenic diseases target the amyloidogenic formation of proteins (reduction), or the clearance rate of misfolded/aggregated proteins (increase); accordingly, the stability of proteins native state could be increased, or direct inhibition of the self-assembly process may be aimed [18]. Multiple studies have reported that small organic molecules containing single or multiple (hetero) aromatic residues, possess in vitro anti aggregation activity [19,20]. This inhibitory effect may be exerted through several mechanism: stopping formation of mature fibrils from monomers [19], preventing both oligomers and fibril formation [21], affecting only oligomers without effect on mature fibrils formation, or block mature fibrils while allowing oligomer formation [22].

    • Oligomeric intermediates in amyloid formation: Structure determination and mechanisms of toxicity

      2012, Journal of Molecular Biology
      Citation Excerpt :

      For example, certain metabolites,143 lipids,27,111 glycosaminoglycanes142 and metal ions144 can promote oligomerization or act as enhancers within the mechanism of amyloid or oligomer formation. Inhibitory factors, by contrast, hold the perspective of being therapeutically relevant,145 and recent research focused on possibilities to interfere with a particular intermediate.146 Specific polyphenols were shown to destabilize amyloid fibrils and oligomers.147,148

    • Design, synthesis and biological evaluation of indane-2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as β-amyloid aggregation inhibitors

      2010, European Journal of Medicinal Chemistry
      Citation Excerpt :

      Over the years small organic molecules containing single or multiple (hetero)aromatic residues very often with phenolic hydroxyls, have been extensively tested for their ability to inhibit Aβ fibrillization in vitro (Chart 1). The detected inhibitors include Congo red [9], furan [10], indole [11–13], and bis-styrylbenzene derivatives [14], stilbenes [15], curcumin [16], quercetin [17], and many other diverse synthetic and natural compounds [18–20]. Several studies have suggested that interactions between aromatic units may play an important role in many areas of chemistry and biochemistry, most notably in molecular recognition and self-assembly [21–24].

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: 41-61-688 49 43. E-mail: [email protected].

    View full text